Becker Richard C, Phillip Owens A, Sadayappan Sakthivel
Division of Cardiovascular Health and Disease, Heart, Lung and Blood Institute, University of Cincinnati College of Medicine, United States of America.
Division of Cardiovascular Health and Disease, Heart, Lung and Blood Institute, University of Cincinnati College of Medicine, United States of America.
Thromb Res. 2020 Aug;192:78-87. doi: 10.1016/j.thromres.2020.05.003. Epub 2020 May 7.
Inflammation is often applied broadly to human disease. Despite its general familiarity, inflammation is highly complex. There are numerous injurious, immune and infectious determinants, functional elements and signaling pathways, ranging from genetic to epigenetic, environmental, racial, molecular and cellular that participate in disease onset and progression, phenotypic heterogeneity, and treatment selection and response. In addition, inflammation can be tissue and organ specific, adding a layer of complexity to achieving a detailed and translatable understanding of its role in health and disease. The following review takes a close look at inflammation in the context of two common heart diseases, hypertrophic cardiomyopathy and hypertensive cardiomyopathy.
炎症常常被广泛应用于人类疾病。尽管人们对其普遍熟悉,但炎症却极为复杂。从基因到表观遗传、环境、种族、分子及细胞层面,有众多损伤性、免疫性和感染性决定因素、功能元件及信号通路参与疾病的发生和发展、表型异质性以及治疗选择和反应。此外,炎症可能具有组织和器官特异性,这为全面且可转化地理解其在健康和疾病中的作用增添了一层复杂性。以下综述将深入探讨肥厚型心肌病和高血压性心肌病这两种常见心脏病背景下的炎症情况。